Virtual | October 6-8, 2026
TUESDAY, OCTOBER 6, 2026
8:00 AM – 10:30 AM
SESSION I (PART 1): PATIENT POPULATION PRIOR TO DIAGNOSIS OF PROSTATE CANCER: SCREENING AND CLINICAL EVALUATION OF MEN WITH CLINICAL SUSPICION
10:30 AM – 1:30 PM
SESSION I (PART 2): PATIENT POPULATION PRIOR TO DIAGNOSIS OF PROSTATE CANCER: SCREENING AND CLINICAL EVALUATION OF MEN WITH CLINICAL SUSPICION
1:30 PM – 2:00 PM
VIP NETWORKING DISCUSSION FOR SPEAKERS AND SPONSORS (BY INVITATION ONLY)
2:00 PM – 3:00 PM
LUNCH BREAK
3:00 PM – 3:40 PM
KEYNOTE PRESENTATIONS
3:40 PM – 6:00 PM
PANEL ON BIOINFORMATICS, ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING FOR A MULTI-MODALITY DATA ANALYSIS FOR PRECISION DIAGNOSIS AND TREATMENT
WEDNESDAY, OCTOBER 7, 2026
8:00 AM – 10:30 AM
SESSION II (PART 1). CLINICAL EVALUATION AND MANAGEMENT OF MEN WITH LOCALIZED AND RECURRENT PROSTATE CANCER
10:30 AM – 12:50 PM
SESSION II (PART 2): CLINICAL EVALUATION AND MANAGEMENT OF MEN WITH LOCALIZED AND RECURRENT PROSTATE CANCER
12:50 PM – 1:45 PM
VIP NETWORKING DISCUSSION FOR SPEAKERS AND SPONSORS (BY INVITATION ONLY)
1:45 PM – 2:15 PM
LUNCH BREAK
2:15 PM – 5:45 PM
SESSION III: POPULATION OF MEN WITH ADVANCED PROSTATE CANCER
5:45 PM – 6:30 PM
VIP NETWORKING DISCUSSION FOR SPEAKERS AND SPONSORS (BY INVITATION ONLY)
THURSDAY, OCTOBER 8, 2026
8:00 AM – 12:00 PM
SESSION IV: PRECISION DIAGNOSTICS AND EMERGING ROLE OF IMAGE-TARGETED, MINIMALLY INVASIVE TREATMENT: Multimodality Diagnostics for Improved Target Definition, Patient Selection, Monitoring & Outcomes
12:00 PM – 12:30 PM
GENERAL DISCUSSION
12:30 PM – 1:00 PM
VIP NETWORKING DISCUSSION FOR SPEAKERS AND SPONSORS (BY INVITATION ONLY)
1:00 PM – 1:30 PM
LUNCH BREAK
1:30 PM – 2:00 PM
KEYNOTE PRESENTATION
2:00 PM – 2:30 PM
PRESENTATION OF WINNING ABSTRACTS
2:30 PM – 4:00 PM
GENERAL DISCUSSION
4:00 PM
ADJOURN


